Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.86 is in line with its 3-year average of 0.80, around the middle of its 3-year range (-0.03–1.52).
41.69% below its 12-month average of 1.48.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.07.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 2 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-15T17:05:43.993Z. Historical observations retain their original dates. Historical series through 2026-09-11.
EARNINGS PER SHARE (EPS)
0.86
EARNINGS PER SHARE (EPS) AVG TTM
1.48
EARNINGS PER SHARE (EPS) AVG 3Y
0.80
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-41.69%
CURRENT VS 3Y AVG
+6.89%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$27.22B
Earnings Per Share (EPS)
9.42
TTM Avg
8.33
3Y Avg
8.09
5Y Avg
9.83
Market Cap
$26.79B
Earnings Per Share (EPS)
44.49
TTM Avg
41.42
3Y Avg
39.43
5Y Avg
36.04
Market Cap
$26.29B
Earnings Per Share (EPS)
12.09
TTM Avg
9.71
3Y Avg
9.57
5Y Avg
13.14
Market Cap
$25.92B
Earnings Per Share (EPS)
7.82
TTM Avg
6.79
3Y Avg
7.36
5Y Avg
7.17
Market Cap
$29.07B
Earnings Per Share (EPS)
3.45
TTM Avg
4.46
3Y Avg
4.05
5Y Avg
4.25
Market Cap
$24.64B
Earnings Per Share (EPS)
7.85
TTM Avg
3.38
3Y Avg
2.74
5Y Avg
2.31
Market Cap
$24.50B
Earnings Per Share (EPS)
-7.76
TTM Avg
-4.08
3Y Avg
9.21
5Y Avg
14.48
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $27.19B | 0.86 | 1.48 | 0.80 | N/A |
| Quest Diagnostics Incorporated (DGX)vs › | $27.22B | 9.42 | 8.33 | 8.09 | 9.83 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.79B | 44.49 | 41.42 | 39.43 | 36.04 |
| Labcorp Holdings Inc. (LH)vs › | $26.29B | 12.09 | 9.71 | 9.57 | 13.14 |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.92B | 7.82 | 6.79 | 7.36 | 7.17 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.07B | 3.45 | 4.46 | 4.05 | 4.25 |
| Incyte Corporation (INCY)vs › | $24.64B | 7.85 | 3.38 | 2.74 | 2.31 |
| BioNTech SE (BNTX)vs › | $24.50B | -7.76 | -4.08 | 9.21 | 14.48 |
| Zoetis Inc. (ZTS)vs › | $30.77B | 6.07 | 5.75 | 5.27 | 4.80 |
| Waters Corporation (WAT)vs › | $31.29B | 4.01 | 10.78 | 11.05 | 10.65 |
Trailing EPS (TTM)
$0.86
Forward EPS (Est.)
$1.49
P/E Ratio
37.4
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 1.43 |
| 2024-12-31 | 1.52 |
| 2023-12-31 | 0.30 |
| 2022-12-31 | -0.03 |
